CAS: 4518-10-9; Methyl 3-Aminobenzoate

上下游产品

CAS号67-56-1 甲醇 | CAS号99-05-8 间氨基苯甲酸 | CAS号618-95-1 3-硝基苯甲酸甲酯 | CAS号618-89-3 3-溴苯甲酸甲酯 | CAS号593-81-7 三甲胺盐酸盐 | CAS号618-91-7 3-碘苯甲酸甲酯 | CAS号148582-24-5 methyl 3-(((ben... | CAS号201230-82-2 carbon monoxide | CAS号591-19-5 3-溴苯胺 | CAS号34240-09-0 3-(benzyloxycar... | CAS号6942-37-6 2-溴-5-氨基苯甲酸甲酯 | CAS号46064-79-3 3-氨基-4-溴苯甲酸甲酯 | CAS号106896-48-4 3-氨基-2-溴苯甲酸甲酯 | CAS号455-68-5 3-氟苯甲酸甲酯 | CAS号3125-66-4 3-甲氧基羰基异硫氰酸苯酯 | CAS号14474-22-7 3-phenyldiazeny... | CAS号41221-47-0 3-羧甲氧基苯基异氰酸酯 | CAS号186086-71-5 3-吡咯烷-1-苯甲酸甲酯 | CAS号192948-00-8 Benzoic acid, 3... | CAS号24830-50-0 m-[Bis(2-chloro...

间氨基苯甲酸置于硫酸体系中,用 甲醇 作为反应溶剂,化学反应 20.0H,以91.2%的收率获得产物3-氨基苯甲酸甲酯
参考文献:三步反应法无催化剂合成芳基二胺
标题:三步反应法无催化剂合成芳基二胺
摘要:与芳基胺形成c-n键是有机化学中研究最广泛的反应之一.尽管如此,它仍然是极具挑战性的,通常需要昂贵的贵金属基催化剂.在这里,我们报告了一种构建c-n键的简便,无催化剂的方法.该方法通过原位形成闭环idi离子进行,从而可以制备一系列对称和/或不对称的芳基二胺,其收率高(82-98%)和纯度,并且具有各种不同的取代基.已证明该方法可成功制备具有对位和/或间位的芳基二胺-取代的羧基,硝基,溴,甲氧基或甲基.这种无催化剂的绿色合成途径仅需三个步骤,并且无需纯化即可进行.此外,这是一种新的可持续的,经济上可行的方法,可以实现原本具有挑战性的键形成.
DOI:10.1021/acs.Joc.8B00151

专利信息

专利号:US-11447454-B2
优先权日:2015-08-07
标题:Synthesis of benzodiazepine derivatives
发明人：BOYCE MALCOLM JAMES; THOMSEN LIV; GILBERT DONALD ALAN; WOOD DAVID
权利人:TRIO MEDICINES LTD
摘要:The invention relates to processes for the synthesis of benzodiazepine derivatives of Formula I:

专利号:US-5998629-A
优先权日:1998-12-02
标题 :Synthesis of pyrazolotriazole photographic dye forming color couplers and intermediates
发明人：BOSE JUDITH A; VALENTE RONALD R; AIMINO DINO; DEMEJO DEBORAH D
权利人:EASTMAN KODAK CO
摘要:Photographic pyrazolotriazole dye forming coupler compound or coupler intermediate compounds can be readily prepared by inducing an elimination-addition reaction between certain pyrazolotriazole compounds and aromatic amines in the presence of an inorganic base or formate. Yields and purity are high, and reaction time is reduced with the specific set of conditions and reactants, and environmental impact from waste is reduced. The resulting compounds can be used themselves as photographic dye forming couplers or further reacted to prepare useful coupler compounds for photographic use.

专利号:US-9533959-B2
优先权日:2013-10-07
标 题:Methods of regioselective synthesis of 2,4-disubstituted pyrimidines
发明人：CHARRIER JEAN-DAMIEN; O'DONNELL MICHAEL EDWARD
权利人:VERTEX PHARMA
摘要:The present invention relates to the novel regioselective syntheses of 2,4-disubstituted pyrimidines through sequential nucleophilic aromatic substitutions.

专利号:US-4002664-A
优先权日:1973-06-09
标题 :Manufacture of dimethylaminobenzenecarboxylic acid esters
发明人：QUADBECK-SEEGER HANS-JUERGEN; HOCH HELMUT
权利人:BASF AG
摘要:Dimethylaminobenzenecarboxylic acid esters are produced by reaction of nitrobenzenecarboxylic acid esters with formaldehyde and hydrogen under pressure in the presence of a hydrogenation catalyst containing metals of atomic numbers 24 to 29 and of a weak acid, at temperatures from 35° to 150° C. The products are starting materials for the synthesis of dyes, especially of crystal violets, and of reactive dyes and pesticides.

专利号:US-2011263540-A1
优先权日:2008-07-25
标题 :Small-molecule inhibitors of protein synthesis inactivating toxins
发明人：PANG YUAN-PING; TUMER NILGUN EREKEN; MILLARD CHARLES B
权利人:PANG YUAN-PING; TUMER NILGUN EREKEN; MILLARD CHARLES B
摘要:Small-molecule inhibitors of a protein synthesis inhibiting toxin, e.g., ricin, abrin, Shiga, and Shiga-like toxins, as well as methods of using the inhibitors are provided. Further provided are methods of identifying small-molecule inhibitors of a protein synthesis inhibiting toxin.

专利号:US-2024400552-A1
优先权日:2016-11-11
标题 :Heterocyclic modulators of lipid synthesis
发明人：BUCKLEY DOUGLAS I; DUKE GREGORY; WAGMAN ALLAN S; EVANCHIK MARC; MCDOWELL ROBERT S
权利人:SAGIMET BIOSCIENCES INC
摘要:Compounds that are fatty acid synthesis modulators are provided. The compounds may be used to treat disorders characterized by dysregulation of the fatty acid synthase function by modulating the function and/or the fatty acid synthase pathway. Methods are provided for treating such disorders including viral infections, such as hepatitis C infection, cancer and metabolic disorders, such as non-alcoholic steatohepatitis (NASH).